The organotypic, or """"""""raft,"""""""" tissue culture system involves culturing epithelial cells at an air-liquid interface so that the cells fully differentiate in a manner similar to that found in vitro. Although initially developed for epidermal cells, the method has been used in this laboratory to provide an in vitro mimic of cell differentiation using foreskin, uterine cervical, vaginal and oral epithelial cells. While normal, e.g. non-infected, human cells display characteristic terminal differentiation on rafts, the phenotype of cells expressing viral genes can range from normal through dysplastic to malignant. This has been particularly well-demonstrated in histological preparations from rafts prepared with cells expressing human papillomavirus (HPV) genes. The raft preparations are also sensitive indicators to toxicity resulting from abnormal gene expression and/or constituents of the medium. The organotypic culture method will provide an ideal approach to the evaluation of the effects of candidate microbicides on cell phenotype, host cell gene expression and viral gene expression. We propose to use vaginal and other human genital area epithelial cells to assess the effects of microbicide compounds on cell viability, cell growth and differentiation. We will investigate the response of viral gene expression, using HPV and HSV-2 gene constructs, and possible effects on virus infectivity. Although HPV virions have not been grown in quantity in vitro, the preparation of recombinant viral capsids will allow studies of receptors, etc.,for that virus to proceed in the near future. We will also examine the effects of the microbicides on the phenotype of cells immortalized by HPV-16 or -18 as a further measure of the inhibition of cellular response to infection. This project will contribute to the overall program by providing a cell biology and molecular biology approach to the evaluation of microbicides, using differentiating relevant human cells in an in vitro setting. The project will interact with Project 1 by establishing primate organotypic cell cultures for further evaluation and comparison with human cells and with project 4, using lipid mixtures in antiviral experiments. This project is dependent upon cooperation with the Chlamydia Core (B) and the Clinical Core (D) for cell, organisms, and tissues.

Project Start
1998-04-01
Project End
1999-09-29
Budget Start
Budget End
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Magee-Women's Hospital of Upmc
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Moncla, Bernard J; Guevara, Peter W; Wallace, James A et al. (2012) The inhibitory activity of typified propolis against Enterococcus species. Z Naturforsch C 67:249-56
Wang, Lin; Sassi, Alexandra Beumer; Patton, Dorothy et al. (2012) Development of a liposome microbicide formulation for vaginal delivery of octylglycerol for HIV prevention. Drug Dev Ind Pharm 38:995-1007
Moncla, B J; Pryke, K; Rohan, L C et al. (2012) Testing of viscous anti-HIV microbicides using Lactobacillus. J Microbiol Methods 88:292-6
Moncla, Bernard J; Pryke, Kara; Rohan, Lisa Cencia et al. (2011) Degradation of naturally occurring and engineered antimicrobial peptides by proteases. Adv Biosci Biotechnol 2:404-408
Skinner, M C; Stamm, W E; Lampe, M L (2009) Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing. Antimicrob Agents Chemother 53:1482-9
Patton, Dorothy L; Sweeney, Yvonne T Cosgrove; Paul, Kathleen J (2009) A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model. Sex Transm Dis 36:350-6
Sassi, Alexandra B; Isaacs, Charles E; Moncla, Bernard J et al. (2008) Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. J Pharm Sci 97:3123-39
Moncla, B J; Pryke, K; Isaacs, Charles E (2008) Killing of Neisseria gonorrhoeae, Streptococcus agalactiae (group B streptococcus), Haemophilus ducreyi, and vaginal Lactobacillus by 3-O-octyl-sn-glycerol. Antimicrob Agents Chemother 52:1577-9
Deslouches, Berthony; Gonzalez, Ivan A; DeAlmeida, Dilhari et al. (2007) De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 60:669-72
Patton, D L; Cosgrove Sweeney, Y T; McCarthy, T D et al. (2006) Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother 50:1696-700

Showing the most recent 10 out of 42 publications